Sortera på relevans Sorterad på datum
Resultat 1 - 1 av 1

Oblique Therapeutics has entered a research collaboration agreement with Eli Lilly and Company to apply the AbiProt[®] technology to generate antibodies to a high-value target

Sammanhang: ...Oblique Therapeutics has entered a research collaboration agreement with Eli Lilly and Company to apply the AbiProt[®] technology to generate antibodies to a high-value target...

di.se - https://www.di.se/pr...-with-eli/ - Datum: 2024-08-22 13:16. - Utan betalvägg »